SEP 8, 2026 · JOURNAL ARTICLE
Targeting Both Oncogenic Signaling and Dependence Receptor Function is Required to Fully Suppress MET Exon 14 Skipping-Driven tumorigenesis
Cancer Research
Mechanistic study using genome editing and mouse models to propose a novel oncogenic mechanism; lacks clinical trial data or human efficacy evidence for therapeutic translation.